Hepatocellular integrity after parenteral nutrition: Comparison of a fish-oil-containing lipid emulsion with an olive-soybean oil-based lipid emulsion

European Journal of Anaesthesiology

Volumn 26, Issue 12, 2009, Pages 1076-1082

  Piper, Swen N ^a   Schade, Ingo ^b   Beschmann, Ralf B ^a   Maleck, Wolfgang H ^a   Boldt, Joachim ^b   Röhm, Kerstin D ^b  

^a Stadtkrankenhaus Frankenthal ^*  (Switzerland)

^b KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

Alpha glutathione s transferase; Fatty acids; Fish oil; Lipid emulsion; Liver; Medium chain triglyceride; Olive oil; Parenteral nutrition

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FISH OIL; GLUTATHIONE TRANSFERASE ALPHA; LIPID EMULSION; OLIVE OIL; SOYBEAN OIL EMULSION; GLUTATHIONE TRANSFERASE; SOYBEAN OIL; TRIACYLGLYCEROL; VEGETABLE OIL;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; LIVER FUNCTION; MALE; PARENTERAL NUTRITION; RANDOMIZED CONTROLLED TRIAL; BLOOD; EMULSION; HOSPITALIZATION; PROSPECTIVE STUDY; TOXIC HEPATITIS;

AGED; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; DOUBLE-BLIND METHOD; DRUG-INDUCED LIVER INJURY; EMULSIONS; FAT EMULSIONS, INTRAVENOUS; FEMALE; FISH OILS; GLUTATHIONE TRANSFERASE; HUMANS; MALE; PARENTERAL NUTRITION; PLANT OILS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SOYBEAN OIL; TRIGLYCERIDES;

EID: 77449119145     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e32832e08e0     Document Type: Article

References (35)

1. Adolph M. Lipid emulsions in parenteral nutrition. Ann Nutr Metab 1999; 43: 1-13.
2. Mayer K, Meyer S, Reinholz-Muhly M, et al. Short-time infusion of fish oilbased lipid emulsions, approved for parenteral nutrition, reduces monocyte proinflammatory cytokine generation and adhesive interaction with endothelium in humans. J Immunol 2003; 171: 4837-4843.
3. Singer P, Shapiro H, Theilla M, et al. Anti-inflammatory properties on omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective. Intensive Care Med 2008; 34: 1580-1592.
4. Antébi H, Mansoor O, Ferrier C, et al. Liver function and plasma antioxidant status in intensive care unit patients requiring total parenteral nutrition: comparison of 2 fat emulsions. J Parenter Enter Nutr 2004; 28: 142-148.
5. Grimm H, Tibell A, Norrlind B, et al. Immunoregulation by parenteral lipids: impact of the n-3 to n-6 fatty acid ratio. J Parenter Enteral Nutr 1994; 18: 417-421.
6. Morlion BJ, Torwesten E, Wrenger K, et al. What is the optimum ω-3 to ω-6 fatty acid ratio of parenteral lipid emulsions in postoperative trauma? Clin Nutr 1997; 16 (Suppl 2): 49.
7. Grimm H. A balanced lipid emulsion. A new concept in parenteral nutrition. Clin Nutr Suppl 2005; 1: 25-30.
8. Kinsella JE, Broughton KS, Whelan JW. Dietary unsaturated fatty acids: interactions and possible needs in relation to eicosanoid synthesis. J Nutr Biochem 1990; 1: 123-141.
9. Grimm H, Kraus A. Immunonutrition: supplementary amino acids and fatty acids ameliorate immune deficiency in critically ill patients. Arch Surg 2001; 386: 369-376.
10. Mertes N, Grimm H, Fü rst P, Stehle P. Safety and efficacy of a new parenteral lipid emulsion (SMOFlipid) in surgical patients: a randomized, double-blind, multicenter study. Ann Nutr Metab 2006; 50: 253-259.
11. Buchman AL, Ament ME, Sohel M, et al. Choline deficiency causes reversible hepatic abnormalities in patients receiving parenteral nutrition: proof of a human cholin requirement: a placebo-controlled trial. J Parenter Enteral Nutr 2001; 25: 260-268.
12. Kumpf VJ. Parenteral nutrition-associated liver disease in adult and pediatric patients. Nutr Clin Prac 2006; 21: 279-290.
13. Porayko MK. Liver dysfunction and parenteral nutritional therapies. Clin Liver Dis 1998; 2: 133-147.
14. Röhm KD, Suttner SW, Boldt J, et al. Insignificant effect of desfluranefentanyl-thiopental on hepatocellular integrity: a comparison with total intravenous anaesthesia using propofol-remifentanil. Eur J Anaesthesiol 2005; 22: 209-214.
15. Ozer J, Ratner M, Shaw M, et al. The current state of serum biomarkers of hepatotoxicity. Toxicology 2008; 245: 194-205.
16. Weimann A, Braga M, Harsanyi L, et al. ESPEN guidelines on enteral nutrition: surgery including organ transplantation. Clin Nutr 2006; 25: 224-244.
17. Piper SN, Röhm KD, Boldt J, et al. Hepatocellular integrity in patients requiring parenteral nutrition: comparison of structured MCT/LCT versus a standard MCT/LCT-and a LCT-emulsion. Eur J Anaesthesiol 2008; 25: 557-565.
18. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med 2001; 134: 657-662. (Pubitemid 32322244)
19. Anmacher DE. A toxicologist's guide to biomarkers of hepatic response. Hum Exp Toxicol 2002; 21: 253-262.
20. Beckett GJ, Hayes JD. Glutathione S-transferases: biomedical applications. Adv Clin Chem 1993; 30: 281-380.
21. Yoo JSH, Hong JY, Ning SM, Yang CS. Role of dietary corn oil in the regulation of cytochromes P450 and glutathione S-transferase in rat liver. J Nutr 1990; 120: 1718-1726.
22. Grau T, Bonet A, Rubio M, et al. Liver dysfunction associated with artificial nutrition in critically ill patients. Crit Care 2007; 11: R10.
23. Baker AL, Rosenberg IH. Hepatic complications of total parenteral nutrition. Am J Med 1987; 82: 489-497.
24. Zamir O, Nussbaum MS, Bhadra S, et al. Effect of enteral feeding on hepatic steatosis induced by total parenteral nutrition. J Parenter Enteral Nutr 1994; 18: 20-25.
25. Lewis SJ, Egger M, Sylvester PA, Thomas S. Early enteral feeding versus 'nil by mouth' after gastrointestinal surgery: systematic review and metaanalysis of controlled trials. BMJ 2001; 323: 773-776.
26. Heyland DK. Nutritional support in the critically ill patients. A critical review of the evidence. Crit Care Clin 1998; 14: 423-440.
27. Röhm KD, Schöllhorn T, Boldt J, et al. Nutrition support and treatment of motility disorders in critically ill patients: results of a survey on German intensive care units. Eur J Anaesthesiol 2008; 25: 58-66.
28. Alwayn IP, Javid PJ, Gura KM, et al. Do polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREPB-1 suppression or by correcting essential fatty acid deficiency. Hepatology 2004; 39: 1176-1177.
29. Alwayn IP, Andersson C, Zauscher B, et al. Omega-3 fatty acids improve hepatic steatosis in a murine model: potential implications for the marginal steatotic liver donor. Transplantation 2005; 79: 606-608.
30. Heller AR, Rössel T, Gottschlich B, et al. Omega-3 fatty acids improve liver and pancreas function in postoperative cancer patients. Int J Cancer 2004; 111: 611-616.
31. Sheth K, Bankey P. The liver as an immune organ. Curr Opin Crit Care 2001; 7: 99-104.
32. Pscheidl E, Schywalsky M, Tschaikowsky K, Böke-Pröls T. Fish oilsupplemented parenteral diets normalize splanchnic blood flow and improve killing of translocated bacteria in a low-dose endotoxin rat model. Crit Care Med 2000; 28: 1489-1496.
33. Piper SN, Haisch G, Kumle B, et al. Effects of esmolol-and sodium nitroprusside-induced controlled hypotension on hepatocellular integrity in patients undergoing endonasal sinus surgery. Anaesthesiol Intensivmed Notfallmed Schmerzther 2003; 38: 781-786.
34. Sailer D, Müller M. Medium chain triglycerides in parenteral nutrition. J Parenter Enteral Nutr 1981; 5: 115-119.
35. Kim H, Son E, Kim J, et al. Association of hyperglycemia and markers of hepatic dysfunction with dextrose infusion rates in Korean patients receiving total parenteral nutrition. Am J Health Syst Pharm 2003; 60: 1760-1766.